SCHEMBL28345882

SCHEMBL28345882

Cc1ncnc2ccc(-c3cnc(N)nc3-c3ccccc3)cc12

nearest known ligand 0.61

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ ADORA1 P30542 15/20 0.61
▸ ADORA2A P29274 10/20 0.59
▸ MAP4K4 O95819 1/20 0.47
▸ PIK3CD O00329 1/20 0.45
▸ PIK3CA P42336 1/20 0.45
▸ PIK3CB P42338 1/20 0.45
▸ MTOR P42345 1/20 0.45
▸ PIK3CG P48736 1/20 0.45
▸ LCK P06239 1/20 0.45
▸ KDR P35968 1/20 0.45
▸ JAK3 P52333 1/20 0.45
▸ MAPK14 Q16539 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ TGFBR1 P36897 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29947093 1.00 ADORA1 (0.61) ADORA1ADORA2AMAP4K4PIK3CDPIK3CA
SCHEMBL23965690 0.89 ADORA1 (0.47) ADORA1ADORA2AMAP4K4LCKKDR
SCHEMBL29947057 0.89 ADORA1 (0.55) ADORA1ADORA2AMAP4K4PIK3CDPIK3CA
SCHEMBL21621288 0.89 ADORA1 (0.55) ADORA1ADORA2AMAP4K4PIK3CDPIK3CA
SCHEMBL29947063 0.83 ADORA2A (0.53) ADORA1ADORA2APIK3CALCKKDR
SCHEMBL21621289 0.83 ADORA2A (0.53) ADORA1ADORA2APIK3CALCKKDR
SCHEMBL28343110 0.83 ADK (0.48) ADORA1ADORA2ALCKKDRJAK3
SCHEMBL30209593 0.83 ADK (0.48) ADORA1ADORA2ALCKKDRJAK3
SCHEMBL20392542 0.81 ADORA2A (0.56) ADORA1ADORA2AMAP4K4
SCHEMBL21621287 0.81 ADORA1 (0.39) ADORA1ADORA2AMAP4K4LCKKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110684020-B 2-aminopyrimidine derivatives, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2023-01-20 — — CN disclosed
CN-110684020-A 2-aminopyrimidine derivatives, preparation method and medical application thereof 江苏恒瑞医药股份有限公司 2020-01-14 — — CN disclosed
Send feedback